 |
Diabetes Mellitus, Type 1 - Drug therapy
Research News and Information
Definition of 'Diabetes Mellitus, Type 1'A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Common names: Diabetes Mellitus, Type 1; Diabetes Mellitus, Insulin-Dependent; Diabetes Mellitus, Insulin Dependent; Insulin-Dependent Diabetes Mellitus; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Juvenile Onset; Juvenile-Onset Diabetes Mellitus; Type 1 Diabetes Mellitus |
Saturday, November 21, 2009
Early progression of the autonomic dysfunction observed in pediatric type 1 diabetes mellitus.
3 Oct 2009 
To focus on early cardiac and vascular autonomic dysfunction that might complicate type 1 diabetes mellitus in children, we planned an observational, cross-sectional study in a population of 93 young patients, under insulin treatment, subdivided in ... Read more...
23 Sep 2009 To demonstrate that the 2-yr clinical follow-up of our patient strongly suggests that long-term therapy with posaconazole (POS) is safe and beneficial in treatment and prevention of relapses of, otherwise fatal, central nervous system mucormycosis. ... Read more...
Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease.
30 Aug 2009 Vitamin D research is discussed in light of the hypothesis that the lower average levels of vitamin D frequently observed in autoimmune disease are not a sign of deficiency. Instead, it is proposed that the lower levels result from chronic infection ... Read more...
Latest indexed articles for 'Diabetes Mellitus, Type 1 - Drug therapy'
These are the very latest articles for this heading:
- Images in clinical medicine. Injection-site lipoatrophy.
3 Nov 2009 - Early progression of the autonomic dysfunction observed in pediatric type 1 diabetes mellitus. 3 Oct 2009
- Renal and retinal effects of enalapril and losartan in type 1 diabetes. 29 Sep 2009
- Renal and retinal effects of enalapril and losartan in type 1 diabetes. 29 Sep 2009
- Who should administer insulin in schools? Sorting out the controversy. 26 Sep 2009
- Long-term posaconazole treatment and follow-up of rhino-orbital-cerebral mucormycosis in a diabetic girl. 23 Sep 2009
- Glycaemic control in patients with type 1 diabetes after provision of public hospital-funded insulin pumps. 5 Sep 2009
- Reversing bacteria-induced vitamin D receptor dysfunction is key to autoimmune disease. 30 Aug 2009
- Pramlintide in pediatric type 1 diabetes. 30 Aug 2009
- Exercise-related hypoglycemia-associated autonomic failure in diabetes. 30 Aug 2009
- Berberine differentially modulates the activities of ERK, p38 MAPK, and JNK to suppress Th17 and Th1 T cell differentiation in type 1 diabetic mice. 4 Aug 2009
- Toxic epidermal necrolysis and neutropaenia: complications of omeprazole. 30 Jul 2009
- Tailoring intensified insulin therapy in children. 30 Jul 2009
- Glucose sensing during hypoglycemia: lessons from the lab. 30 Jul 2009
- American Diabetes Association--69th Scientific sessions. Hyperinsulinism, insulin resistance and the treatment of diabetes: Part 2. 30 Jul 2009
- Insulin pump therapy for type 1 diabetes treatment in a girl with Down's syndrome. 30 Jul 2009
- Change you can B(cell)eive in: recent progress confirms a critical role for B cells in type 1 diabetes. 30 Jul 2009
- Role of statins in diabetes complications. 30 Jul 2009
- [Treatment with insulin pump during hospital care should be questioned. Three cases illustrate the risk of ketoacidosis] 30 Jul 2009
- Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity. 30 Jul 2009
See a longer list of these articles.
Technical information about 'Diabetes Mellitus, Type 1'
Definition: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
Descriptor UI: D003922
Alternative terms: Diabetes Mellitus, Type 1; Diabetes Mellitus, Insulin-Dependent; Diabetes Mellitus, Insulin Dependent; Insulin-Dependent Diabetes Mellitus; Diabetes Mellitus, Juvenile-Onset; Diabetes Mellitus, Juvenile Onset; Juvenile-Onset Diabetes Mellitus; Type 1 Diabetes Mellitus; Diabetes Mellitus, Sudden-Onset; Diabetes Mellitus, Sudden Onset; Mellitus, Sudden-Onset Diabetes; Sudden-Onset Diabetes Mellitus; Diabetes Mellitus, Type I; IDDM; Diabetes Mellitus, Brittle; Brittle Diabetes Mellitus; Diabetes Mellitus, Ketosis-Prone; Diabetes Mellitus, Ketosis Prone; Ketosis-Prone Diabetes Mellitus; Diabetes, Autoimmune; Autoimmune Diabete; Diabete, Autoimmune; Autoimmune Diabetes;
Related Mesh Headings: Mice, Inbred NOD;
Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;
Tree Number: C18.452.394.750.124; C19.246.267; C20.111.327;
History Note: 2005 (1984)
Technical Notes: MICE, INBRED NOD are a common model for this disease